英文名稱 | Lixisenatide |
---|---|
中文名稱 | 利西拉來(lái);利西拉肽 |
CAS號(hào) | 320367-13-3 |
分子式 | C215H347N61O65S |
分子量 | 4,858.49 |
MDL | MFCD13194768 |
外觀 | White to pink powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5 days | ¥1168.00 | 登錄后可見(jiàn) | |
2 mg | 3-5 days | ¥1866.00 | 登錄后可見(jiàn) | |
5 mg | 3-5 days | ¥2966.00 | 登錄后可見(jiàn) |
英文名稱 | Lixisenatide |
---|---|
中文名稱 | 利西拉來(lái);利西拉肽 |
CAS號(hào) | 320367-13-3 |
分子式 | C215H347N61O65S |
分子量 | 4,858.49 |
MDL | MFCD13194768 |
外觀 | White to pink powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
PMID: 35498599 PMCID: PMC9050383 DOI: 10.1039/c9ra09959j
Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats [J].
PMID: 33065146 DOI: 10.1016/j.lfs.2020.118592
PMID: 31336333 DOI: 10.1016/j.intimp.2019.105732